We're currently experiencing extremely high call volumes. We're very sorry for any inconvenience this might cause.

If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

BioPharma Credit Investments (BPCR) Ord

Sell:$0.86 Buy:$0.87 0 Change: $0.016 (1.83%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.016 (1.83%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.016 (1.83%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BioPharma Credit Plc is a closed-ended investment company. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly holds an interest in royalty rights to certain products, including any investment vehicle or special purpose vehicle. The Company's un-invested capital may be invested in cash instruments or bank deposits for cash management purposes. The Company may, from time to time, enter into such hedging or other derivative arrangements. The Company's investment manager is Pharmakon Advisors L.P.

Contact details

Beaufort HSE, 51 New North Road
United Kingdom
+ (0)

Important dates

Future events
AGM 20 May 2020 20/05/20
Past events
Special dividend payment date 27 March 2020 27/03/20
Interim dividend payment date 27 March 2020 27/03/20
Final results 10 March 2020 10/03/20
Annual report 10 March 2020 10/03/20
Interim ex-dividend date 27 February 2020 27/02/20
Special ex-dividend date 27 February 2020 27/02/20
Interim dividend payment date 17 December 2019 17/12/19
Interim ex-dividend date 14 November 2019 14/11/19
Interim dividend payment date 20 September 2019 20/09/19
Interim results 04 September 2019 04/09/19
Interim ex-dividend date 15 August 2019 15/08/19
Interim dividend payment date 21 June 2019 21/06/19
AGM 19 June 2019 19/06/19
Interim ex-dividend date 23 May 2019 23/05/19

General stock information

Market cap:
$1.18 billion
Shares in issue:
1.37 billion
No specific Industry
London Stock Exchange
US dollar

Key personnel

  • Jeremy Sillem
    Chairman of the Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.